| Views | |
|---|---|
| Development and characterisation of buparvaquone nanosuspensions for pulmonary delivery in the treatment of Pneumocystis pneumonia | 420 |
| April 2025 | May 2025 | June 2025 | July 2025 | August 2025 | September 2025 | October 2025 | |
|---|---|---|---|---|---|---|---|
| Development and characterisation of buparvaquone nanosuspensions for pulmonary delivery in the treatment of Pneumocystis pneumonia | 9 | 3 | 11 | 19 | 8 | 9 | 20 |
| Views | |
|---|---|
| 3_Chapter3_Materials_Methods.pdf | 303 |
| 6_Chapter6_References.pdf | 294 |
| 1_Chapter1_Introduction_aims_objectives.pdf | 224 |
| 0_Title_Index.pdf | 189 |
| 7_Chapter7_Appendices_Aknowledgements.pdf | 185 |
| 2_Chapter2_Literature_review.pdf | 153 |
| 4_Chapter4_Results_Discussions.pdf | 152 |
| 5_Chapter5_Summary_Zusammenfassung.pdf | 105 |
